| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials KF Schulz, DG Altman, D Moher Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010 | 18677 | 2010 |
| CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ... International journal of surgery 10 (1), 28-55, 2012 | 10034 | 2012 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 6335 | 2014 |
| Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group Physical therapy 89 (9), 873-880, 2009 | 2417 | 2009 |
| CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ... PLoS medicine 5 (1), e20, 2008 | 669 | 2008 |
| Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison L Shamseer, D Moher, O Maduekwe, L Turner, V Barbour, R Burch, ... BMC medicine 15 (1), 1-14, 2017 | 362 | 2017 |
| The Hong Kong Principles for assessing researchers: Fostering research integrity D Moher, L Bouter, S Kleinert, P Glasziou, MH Sham, V Barbour, ... PLoS Biology 18 (7), e3000737, 2020 | 269 | 2020 |
| Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration V Welch, M Petticrew, J Petkovic, D Moher, E Waters, H White, P Tugwell, ... Journal of Clinical Epidemiology 70, 68-89, 2016 | 208 | 2016 |
| Retractions: guidance from the Committee on Publication Ethics (COPE) E Wager, V Barbour, S Yentis, S Kleinert Maturitas 64 (4), 201-203, 2009 | 135 | 2009 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2016 | 130* | 2016 |
| UK Biobank: a project in search of a protocol? V Barbour The Lancet 361 (9370), 1734-1738, 2003 | 114 | 2003 |
| Making sense of non-financial competing interests PLoS Medicine Editors PLoS Medicine 5 (9), e199, 2008 | 107 | 2008 |
| Nephrotic syndrome associated with sulphasalazine. VM Barbour, PF Williams BMJ: British Medical Journal 301 (6755), 818, 1990 | 74 | 1990 |
| α-Thalassemia resulting from a negative chromosomal position effect VM Barbour, C Tufarelli, JA Sharpe, ZE Smith, H Ayyub, CA Heinlein, ... Blood, The Journal of the American Society of Hematology 96 (3), 800-807, 2000 | 54 | 2000 |
| Optimal evidence in difficult settings: improving health interventions and decision making in disasters M Gerdin, M Clarke, C Allen, B Kayabu, W Summerskill, D Devane, ... PLoS medicine 11 (4), e1001632, 2014 | 53 | 2014 |
| Core competencies for scientific editors of biomedical journals: consensus statement D Moher, J Galipeau, S Alam, V Barbour, K Bartolomeos, P Baskin, ... BMC medicine 15 (1), 1-10, 2017 | 52 | 2017 |
| A scoping review of competencies for scientific editors of biomedical journals J Galipeau, V Barbour, P Baskin, S Bell-Syer, K Cobey, M Cumpston, ... BMC medicine 14, 1-17, 2016 | 46 | 2016 |
| How ghost-writing threatens the credibility of medical knowledge and medical journals V Barbour haematologica 95 (1), 1, 2010 | 44 | 2010 |
| Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors L Ramamurthy, V Barbour, A Tuckfield, DR Clouston, D Topham, ... Journal of Biological Chemistry 276 (11), 7836-7842, 2001 | 44 | 2001 |
| Ten simple rules for building and maintaining a scientific reputation PE Bourne, V Barbour PLoS computational biology 7 (6), e1002108, 2011 | 43 | 2011 |
